ARTICLE | Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

A conversation with Aviv Regev on how single cell research can shape drug development

August 1, 2020 12:05 AM UTC

Single cell pioneer Aviv Regev thinks the gene networks revealed by the technology are on the verge of delivering new ways to attack disease biology.

Her emphasis is on the idea that uncovering how genes are organized into modular programs will reveal more about cellular pathology than focusing on individual genes, and make it possible for researchers to measure less and predict more...

BCIQ Company Profiles

Genentech Inc.